4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001507650-26-000009
Co-Chief Executive Officer acquired 500,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Zanganeh Mahkam · Co-Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 1 in the form | +500,000 | $1.06 | $530,000 | 531,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −500,000 | 800,000 | D |
Loading xslF345X06/wk-form4_1794878629.xml…